<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000046016"><TermName>prinomastat</TermName><TermPronunciation>(prih-NOH-muh-stat)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It is a matrix metalloproteinase inhibitor and belongs to the family of drugs called angiogenesis inhibitors. Also called AG3340.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731349" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;prinomastat&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731348" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;prinomastat&quot;" language="es" id="_4"/><SpanishTermName>prinomastat</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un inhibidor de la metaloproteasa de matrizy un tipo de inhibidor de la angiogénesis. También se llama AG3340.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2005-02-15</DateLastModified></GlossaryTerm>
